Kuo-Hsuan Hsu
10PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jul 01, 2025
Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and Radiotherapy.Tzu-I Chuang, Kuo-Hsuan Hsu, Po-Hsin Lee
|Jan 08, 2025
Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation.Mu-Han Peng, Yen-Hsiang Huang, Kuo-Hsuan Hsu
|Nov 01, 2024
Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer.Wei-Fan Ou, Kuo-Hsuan Hsu, Jeng-Sen Tseng
|Sep 30, 2024
Using a Polygenic Risk Score to Improve the Risk Prediction of Non-Small Cell Lung Cancer in Taiwan.Po-Hsin Lee, I-Chieh Chen, Yi-Ming Chen
|Jul 13, 2024
Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination.Po-Hsin Lee, Wei-Fan Ou, Yen-Hsiang Huang
|Jan 08, 2024
Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib.Jia-Jun Wu, Jeng-Sen Tseng, Zhe-Rong Zheng
Pageof 2
Frequent Collaborators
7 joint publications
Jia-Jun Wu
3 joint publications
Gee-Chen Chang
3 joint publications
Yen-Hsiang Huang
2 joint publications
Yu-Wei Hsu
1 joint publications
Jing-Wen Huang
1 joint publications
Wei-Yu Liao
1 joint publications
Kuan-Chih Chen
1 joint publications
Cheng-Hsiang Chu
1 joint publications
Tsung-Ying Yang
1 joint publications
Po-Hsin Lee
